BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 32106841)

  • 21. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial.
    Virtanen A; Nieminen P; Luostarinen T; Anttila A
    Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1960-9. PubMed ID: 21752985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
    Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
    Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
    Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genital self-sampling for HPV-based cervical cancer screening: a qualitative study of preferences and barriers in rural Ethiopia.
    Brandt T; Wubneh SB; Handebo S; Debalkie G; Ayanaw Y; Alemu K; Jede F; von Knebel Doeberitz M; Bussmann H
    BMC Public Health; 2019 Jul; 19(1):1026. PubMed ID: 31366402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London.
    Szarewski A; Cadman L; Ashdown-Barr L; Waller J
    J Med Screen; 2009; 16(4):193-8. PubMed ID: 20054094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
    Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
    BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
    Lam JU; Rebolj M; Møller Ejegod D; Pedersen H; Rygaard C; Lynge E; Thirstrup Thomsen L; Krüger Kjaer S; Bonde J
    Int J Cancer; 2017 May; 140(10):2212-2219. PubMed ID: 28195317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening.
    Darlin L; Borgfeldt C; Forslund O; Hénic E; Hortlund M; Dillner J; Kannisto P
    J Clin Virol; 2013 Sep; 58(1):155-60. PubMed ID: 23867008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Wong ELY; Cheung AWL; Huang F; Chor JSY
    Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening.
    Tamalet C; Le Retraite L; Leandri FX; Heid P; Garnier HS; Piana L
    Clin Microbiol Infect; 2013 Jan; 19(1):E44-E50. PubMed ID: 23137168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives.
    Wood B; Lofters A; Vahabi M
    Curr Oncol; 2018 Feb; 25(1):e8-e16. PubMed ID: 29507490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
    Arbyn M; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):769-72. PubMed ID: 25713024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter.
    Giorgi Rossi P; Fortunato C; Barbarino P; Boveri S; Caroli S; Del Mistro A; Ferro A; Giammaria C; Manfredi M; Moretto T; Pasquini A; Sideri M; Tufi MC; Cogo C; Altobelli E;
    Br J Cancer; 2015 Feb; 112(4):667-75. PubMed ID: 25633037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
    Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
    BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pairing community health workers with HPV self-sampling for cervical cancer prevention in rural Haiti.
    Mandigo M; Frett B; Laurent JR; Bishop I; Raymondville M; Marsh S; Kobetz E
    Int J Gynaecol Obstet; 2015 Mar; 128(3):206-10. PubMed ID: 25468050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muslim immigrant women's views on cervical cancer screening and HPV self-sampling in Ontario, Canada.
    Vahabi M; Lofters A
    BMC Public Health; 2016 Aug; 16(1):868. PubMed ID: 27557928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-sampling HPV test in women not undergoing Pap smear for more than 5 years and factors associated with under-screening in Taiwan.
    Chou HH; Huang HJ; Cheng HH; Chang CJ; Yang LY; Huang CC; Chang WY; Hsueh S; Chao A; Wang CJ; Tang YH; Lin CT; Qiu JT; Chen MY; Chen CY; Huang KG; Tsai TC; Chang TC; Lai CH
    J Formos Med Assoc; 2016 Dec; 115(12):1089-1096. PubMed ID: 26723863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of women's likelihood of vaginal self-sampling for human papillomavirus to screen for cervical cancer in Taiwan: a cross-sectional study.
    Chen SL; Hsieh PC; Chou CH; Tzeng YL
    BMC Womens Health; 2014 Nov; 14():139. PubMed ID: 25420580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HPV self-sampling for cervical cancer screening in Denmark].
    Tranberg M; Andersen B
    Ugeskr Laeger; 2018 Nov; 180(48):. PubMed ID: 30518468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.